DanielMooreMDPhD

Pediatric Diabetes Endocrinology

Associate Professor, Pediatrics and Pathology, Microbiology&Immunology, Vanderbilt University School of Medicine

Dr. Moore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-4916

Fax+1 615-936-0605

Dr. Daniel Moore is a pediatric endocrinologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 13 years. He specializes in General Pediatric Endocrinology, Pediatric Diabetes Endocrinology and is experienced in Transplant immunology, Autoimmune disease, Immune therapy, Immune Tolerance, Islet Transplantation.

Vanderbilt University Medical CenterFellowship, Pediatric Endocrinology, 2007 - 2010
Vanderbilt University Medical CenterResidency, Pediatrics, 2004 - 2007
Perelman School of Medicine at the University of PennsylvaniaClass of 2004

PubMed

Preparing Physician-Scientists for the Future of Academic Medicine.
Audrea M Burns, Daniel J Moore, Caroline E Rassbach, Debra Boyer, Candace Gildner
Pediatrics. 2024-11-01
4 citations
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.
Christine Bender, Alice E Wiedeman, Alex Hu, Alyssa Ylescupidez, William K Sietsema
Science Translational Medicine. 2024-05-08
2 citations
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes.
John Virostko, Jordan J Wright, Jonathan M Williams, Melissa A Hilmes, Taylor M Triolo
Diabetes Care. 2024-03-01

Journal Articles

Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1–Dependent Neonatal Murine Sepsis Lethality
James L Wynn, John T Benjamin, Daniel J Moore, The Journal of Immunology

How B lymphocytes prevent transplantation tolerance in T1DBeatson Foundation2019–2021
Career Development Award: Mapping a Cure By Defining the B Lymphocyte Signaling NetworkJuvenile Diabetes Research Foundation2014–2019
The Contribution of B Lymphocytes to T1D Reversal by ImatinibNIH2016–2018
High Throughput Identification of Treg Activating MoleculesNIH2015–2017
Breakthrough Therapeutics InitiativeLeona B and Harry M Helmsley Trust2014–2015
RESTORATION OF IMMUNE TOLERANCE IN TYPE 1 DIABETESNIDDK2012–2014
NIH Career Development AwardNIDDK2011–2014
Ruth L Kirschstein NIH F32 FellowshipNIDDK2008–2010